TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia.

Ragy R Girgis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.